Author:
Mehta Shruti H.,Genberg Becky L.,Astemborski Jacquie,Kavasery Ravi,Kirk Gregory D.,Vlahov David,Strathdee Steffanie A.,Thomas David L.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health(social science)
Reference44 articles.
1. Recommendations for prevention, control of hepatitis C virus (HCV) infection and HCV-related chronic disease. (1998). Centers for disease control and prevention. Morbidity and Mortality Weekly Report, 47, 1–39.
2. Thomas, D. L., Vlahov, D., Solomon, L., et al. (1995). Correlates of hepatitis C virus infections among injection drug users. Medicine, 74, 212–220.
3. Bell, J., Batey, R. G., Farrell, G. C., Crewe, E. B., Cunningham, A. L., & Byth, K. (1990). Hepatitis C virus in intravenous drug users. The Medical Journal of Australia, 153, 274–276.
4. van Ameijden, E. J., Van den Hoek, J. A., Mientjes, G. H., & Coutinho, R. A. (1993). A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. European Journal of Epidemiology, 9, 255–262.
5. Mathei, C., Buntinx, F., & van Damme, D. P. (2002). Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: A systematic review. Journal of Viral Hepatitis, 9, 157–173.
Cited by
298 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献